Major pharmaceutical companies, including Eli Lilly, Johnson & Johnson, and AbbVie, are significant holdings in various health care ETFs.
6 reports, 2 independent
Updated Oct 6
Gone quiet
- Reports
- 6
- Developments
- 4
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Major pharmaceutical companies, including Eli Lilly, Johnson & Johnson, and AbbVie, are significant holdings in various health care ETFs.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- AbbVie, Johnson & Johnson, and Eli Lilly are noted as top holdings in specific healthcare ETFs.Sub-event
- The Vanguard Health Care ETF holds major positions in Eli Lilly and Company and Johnson & Johnson.Sub-event
Multiple major pharma/biotech firms, including J&J, AbbVie, and Amgen, are top holdings in various healthcare ETFs.1 source
ETFs are tracking major pharmaceutical businesses, including Eli Lilly, J&J, and AbbVie.1 source
Keep exploring
The entities involved
-
Eli Lilly and Company
American pharmaceutical company
-
Johnson & Johnson
U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer
-
AbbVie
pharmaceutical company
Related events
- AbbVie, Eli Lilly, and Merck are broadening their therapeutic reach.
- Eli Lilly and Company and BeOne Medicines Ltd. are both identified as major players in the medical sector.
- Financial results and stock performance comparisons among AbbVie, Johnson & Johnson, Eli Lilly, and Merck.
- A fund prospectus was filed with the SEC, and Eli Lilly now constitutes about 17% of assets in the Health Care Select Sector SPDR Fund.
- CRISPR Therapeutics, Eli Lilly, and Johnson & Johnson are noted as major holdings in health care ETFs.